24 Week (6 Month) clinical trial intervention study, which involves taking a nasal spray every day for three months, with a follow up visit three months later.
You and your child will first be asked to come in for a screening session; through talking with you and completing some assessments we will determine if your child meets eligibility criteria. If your child meets criteria, then you will then receive either Oxytocin (Syntocinon®) or placebo. Visits will take place every two weeks while your child is taking the drug or placebo.
This study also has an optional continuation part, which means that if you were given placebo, you will be able to take Oxytocin (Syntocinon®) at the end of the six months. The same tests and procedures will be followed that were followed during the main study.